IPSC CENTURY THERAPEUTICS INC Other Situations 8-K Filing 2023 - Clinical Data Presentation Century Therapeutics, Inc. announced initial clinical data from a single-patient case study supporting a multi-dosing strategy for CAR iNK at the 65th American Society of Hematology Annual Meeting.Get access to all SEC 8-K filings of the CENTURY THERAPEUTICS INC